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S U M M A R Y
Objective: This nationwide study aimed to estimate the risk of pneumonia during a 90-day period
following diagnosis with pyogenic liver abscess (PLA) compared to individuals who did not suffer PLA.
Methods: We investigated the incidence of pneumonia during the 90 days after diagnosis of PLA among
12 868 patients who received medical services for this condition, and compared it to that of 64 340
controls who received medical services for other medical conditions.
Results: We found that the incidence rates of pneumonia were 9.59 and 1.87 per 10 000 person-days in
patients with and without PLA, respectively. Stratiﬁed Cox proportional hazard regressions found that
the hazard ratio for pneumonia among patients with PLA was 5.28 times higher than that of patients
without PLA after adjusting for potential confounding factors. We further found Klebsiella pneumoniae to
be the causative organism in 84.9% of the cases, but in only 11.7% of the comparison group.
Conclusions: Our study suggests an increased risk of pneumonia among individuals who have suffered a
PLA.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Pyogenic liver abscess (PLA) is a potentially fatal disease. It
currently accounts for three-quarters of all liver abscesses
occurring in industrialized countries,1 with one out of every
4500–7000 hospital admissions being due to a liver abscess.2,3
Prior to the 1980s, the most commonly isolated organism from
liver abscesses was Escherichia coli, but in Taiwan there has been a
shift to Klebsiella pneumoniae, which is now highly endemic and
the major cause of community-acquired pyogenic infections.4–7
Some researchers are now suggesting that this same etiologic shift
is occurring in the USA,8 with K. pneumoniae recently being found
to be the primary causative agent there as well.9 In addition to this
etiologic shift, other factors affecting the prognosis of PLA include
advancements in antibiotics and surgical techniques, which have
greatly reduced mortality rates over the last two decades.10
Although the treatment of PLA continues to evolve and is
currently a topic of controversy among medical practitioners,11
surgical advancements have recently yielded mortality rates around
11.24%.12 This can be compared with rates that were as high as 69%* Corresponding author. Tel.: +886 2 2736 1661 ext. 3613; fax: +886 2 2378 9788.
E-mail address: henry11111@tmu.edu.tw (H.-C. Lin).
1 Both authors have equal contribution to this manuscript.
1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.01.016among PLA patients afﬂicted between 1928 and 1937,12 and 24% in a
study conducted more recently on patients in the USA between 1966
and 1978.13 On account of the decreased mortality rates and
increased number of PLA survivors, clinicians need to be more aware
of the comorbidities related to having suffered a PLA.
PLA patients often have high rates of bacteremia and subse-
quent metastatic complications, and even higher rates of both
when afﬂicted by K. pneumoniae as the causative agent.4,14
Therefore, it is possible that many future survivors of PLA will
suffer from bacterial infections subsequent to their original PLA
infections. Based on these elements, we hypothesize that patients
with PLA will have a subsequent higher incidence of pneumonia
than individuals without PLA.5,6,15,16
Thus, on account of the possible association between PLA and
cases of pneumonia characterized by high rates of early mortality,
this study set out to estimate the risk of pneumonia within 90 days
following a diagnosis of PLA compared to patients without PLA,
utilizing a nationwide population-based dataset in Taiwan.
2. Methods
2.1. Database
The data for the analyses performed in this study were retrieved
from Taiwan’s National Health Insurance Research Databaseses. Published by Elsevier Ltd. All rights reserved.
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Insurance (NHI) program and is maintained by the National Health
Research Institute, Taipei, Taiwan. The NHIRD includes the
registration ﬁles and original claims data for the reimbursements
of 22.89 million of the country’s 22.96 million inhabitants as of
2008.
2.2. Study population
We used a study cohort and a comparison cohort to examine the
relationship between pneumonia and PLA. For the study cohort, we
retrieved 14 343 patients from the NHIRD who visited outpatient
care centers or were hospitalized with a principal diagnosis of PLA
(International Classiﬁcation of Diseases, ninth revision, Clinical
Modiﬁcation (ICD-9-CM) code 572.0) between January 1, 2006 and
December 31, 2008. In Taiwan, if a physician suspects PLA the
patient ﬁrst undergoes sonography or a computed tomography
scan. If an abscess is visualized and it is of sufﬁcient size, it is
aspirated with a needle and drained. A pus culture is conducted in
every case to determine the etiology and the results must be coded
in the administrative database to receive reimbursement for the
test. If the abscess is too small to be aspirated, a blood culture is
performed instead. The patient’s ﬁrst visit for PLA during this study
period was assigned as the index date. We ﬁrst excluded patients
who had been diagnosed with PLA prior to their index date
(n = 1154) in order to include only new onset patients. Then we
excluded patients aged <18 years (n = 148) in order to include only
an adult population. We also excluded patients who had received a
diagnosis of pneumonia within 6 months prior to their index date
(n = 173). Ultimately, there were 12 868 patients with PLA in the
study cohort.Table 1
Demographic characteristics and comorbid medical disorders of patients in Taiwan w
2006–2008 (N = 77 208)
Variable Patients with PLA (n = 12 868) 
Total No. % 
Sex 
Male 7875 61.2 
Female 4993 38.8 
Age, years 
18–39 1173 9.1 
40–49 1778 13.8 
50–59 3073 23.9 
60–69 2727 21.2 
70–79 2676 20.8 
>79 1441 11.2 
Hypertension 6516 50.6 
Diabetes 5057 39.3 
Heart diseasea 2682 20.8 
Lung diseaseb 1164 9.1 
Acute/chronic kidney disease 1435 11.2 
Total No. Column % 
Monthly income, NT$ 
0–15 840 5899 45.8 
15 841–25 000 4565 35.5 
25 001 2404 18.7 
Geographic region 
Northern 5661 44.0 
Central 3057 23.8 
Southern 3814 29.6 
Eastern 336 2.6 
Urbanization level 
1 (most urbanized) 3600 28.0 
2 3469 26.9 
3 2055 16.0 
4 2035 15.8 
5 (least urbanized) 1709 13.3 
a Heart disease: ischemic heart disease, arrhythmias, and heart failure.
b Lung disease: chronic obstructive pulmonary disease, asthma, pulmonary emphyseIn this study, we used the NHIRD to select a comparison cohort.
A total of 64 340 subjects were randomly extracted from the
NHIRD, at a ratio of 1:5, matched with the study cohort on age, sex,
and the year of index date (2006–2008). The date of ﬁrst medical
services occurring in the index year was assigned as the index date.
We also ensured that none of the selected comparison cohort had a
history of PLA since the initiation of the Taiwan NHI program. In
addition, we ensured that all the selected comparison subjects had
not been diagnosed with pneumonia during the 6 months
preceding their index date.
As a result, we included 77 208 subjects in this study and
individually tracked each subject for 90 days beginning with
their index date to identify those who were subsequently
diagnosed with pneumonia (ICD-9-CM codes 480–483.8, 485–
486, and 487.0). In Taiwan, all pneumonia cases are hospitalized,
receive a chest radiograph, and undergo microbiological tests to
ascertain the causative organism. The ﬁrst microbiological tests
include a culture of the sputum and a Gram stain smear. If the
culture is unsuccessful, the blood may be tested as well as the
urine for pneumococcal antigen. The results of these tests must
also be coded for in the administrative database to receive
reimbursement.
2.3. Statistical analysis
We used the SAS statistical package for all statistical analyses.
Pearson Chi-square tests were used to examine the distributions of
urbanization level, geographic region (northern, central, eastern,
and southern Taiwan), and monthly income of both patients with
and without PLA. We also performed a Kaplan–Meier survival
analysis and log-rank test to detect differences in the risk ofith pyogenic liver abscess (PLA) and patients in the comparison cohort (no PLA),












28 265 43.9 <0.001
13 081 20.3 <0.001
11 736 18.2 <0.001
5734 8.9 0.628
3685 5.7 <0.001

















Figure 1. Pneumonia-free survival rates for patients with pyogenic liver abscess and
comparison patients in Taiwan.
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proportional hazards regressions (stratiﬁed on age, sex, and the
year of index date) were conducted to calculate the hazard of
pneumonia following a diagnosis of PLA. In this study, we also took
several medical comorbidities into consideration in the regression
model, including hypertension, diabetes, heart disease, lung
disease, and acute/chronic kidney disease. These comorbidities
were only included if they either occurred in an inpatient setting or
appeared in two or more ambulatory care claims coded 6 months
before the index date. A p-value of <0.05 was considered
statistically signiﬁcant.
3. Results
The mean age of the total 77 208 sampled subjects was 62.2 (
15.2) years; 61% were males. We found that K. pneumoniae (ICD-9-CM
code 041.3) was the causative organism in 73.2% of the patients with
PLA in this study. After matching for age and sex, it was found that
patients with PLA were more likely than patients without PLA to have
the following comorbidities: hypertension (p < 0.001), diabetes
(p < 0.001), heart disease (p < 0.001), and acute/chronic kidney
disease (p < 0.001) (Table 1). There was no signiﬁcant difference in
the prevalence of lung disease between patients with and without
PLA (p = 0.628). In addition, it was found that patients with PLA had a
greater tendency to have no monthly income and to reside in the
southern part of Taiwan and in less urbanized communities than
patients without PLA (Table 1).
The incidence of pneumonia during the 90-day follow-up
period for these two cohorts is presented in Table 2. Of the total
77 208 sample, 2193 (2.8%) subjects were diagnosed with
pneumonia during the 90-day follow-up period; pneumonia was
found in 1109 (8.6%) patients with PLA and 1084 (1.7%) patients
without PLA. The incidence rates of pneumonia were 9.59 (95%
conﬁdence interval (CI) 9.03–10.15) and 1.87 (95% CI 1.76–1.99)
per 10 000 person-days in patients with and without PLA,
respectively. We used the log-rank test to test the difference in
the 90-day pneumonia-free survival rate between these two
cohorts. It was found that patients with PLA had signiﬁcantly lower
90-day pneumonia-free survival rates than patients without PLA
(Chi-square value 2248.8; p < 0.001). Figure 1 shows the results of
the Kaplan–Meier survival analysis.
The crude hazard ratios (HR) for pneumonia between patients
with and without PLA are also displayed in Table 2. A stratiﬁed Cox
proportional hazards regression (stratiﬁed on age and sex)
revealed that when compared to patients without PLA, the crude
HR for pneumonia among patients with PLA was 5.64 (95% CI 5.17–
6.15).
After adjusting for patient monthly income, geographic
location, urbanization level, hypertension, diabetes, heart disease,
lung disease, and acute/chronic kidney disease, the HR for
pneumonia among patients with PLA was 5.28 (95% CI 4.81–
5.78) times that of patients without PLA (Table 3). We further
analyzed the etiology of pneumonia cases in this investigation andTable 2
Crude and adjusted hazard ratios for pneumonia among the sample patients during the




Incidence rate per 10 000 person-days (95% CI) 3.16 (3.03–3.29) 
Crude HR (95% CI) – 
PLA, pyogenic liver abscess; HR, hazard ratio; CI, conﬁdence interval. Hazard ratio was c
a Indicates p < 0.001.found K. pneumoniae to be the causative organism in 84.9% of the
cases, but only 11.7% of the comparison cohort.
4. Discussion
To the best of our knowledge, this is the ﬁrst study to
demonstrate that PLA infection is a potential risk factor for
subsequent pneumonia. This study found the adjusted HR for
pneumonia among patients with PLA to be 5.28 times higher than
that of patients without PLA.
One explanation for our results stems from the increasing
number of PLA survivors. Studies conducted in the USA show that
the mortality rate of PLA cases has dropped from rates as high as
69% in the early 1900s,12 to 24% in the 1960s and 1970s,13 and are
now, on account of modern surgical techniques, as low as 11.24%.12
This decreasing trend in mortality rates has yielded far more PLA
survivors. As a result the case numbers are now sufﬁcient to
provide the statistical power required to conduct large-scale
epidemiological studies; there is also an increased need for such
studies to better understand this emerging demographic of PLA
survivors.
A second explanation for our ﬁndings could be related to the
etiologic shift among PLA cases. Prior to the 1980s, the most
common organism isolated from PLAs was E. coli. In Taiwan,
however, there has been a shift towards K. pneumoniae as the major
cause of all community-acquired pyogenic infections.4–7 In our 90-day follow-up period starting from the index ambulatory care visit (N = 77 208)
Patients with PLA Comparison group
 No. % No. %
.8 1109 8.6 1084 1.7
9.59 (9.03–10.15) 1.87 (1.76–1.99)
5.64a (5.17–6.15) 1.00
alculated by stratiﬁed Cox regression model (stratiﬁed on age, sex, and index date).
Table 3
Adjusted hazard ratios for pneumonia during the 90-day follow-up period for
patients with pyogenic liver abscess and comparison patients in Taiwan
(N = 77 208)
Variables Pneumonia occurrence
HR 95% CI p-Value
Pyogenic liver abscess 5.28 4.81–5.78 <0.001
Hypertension 0.90 0.82–0.99 0.041
Diabetes 1.29 1.17–1.42 <0.001
Heart disease 1.10 0.99–1.23 0.067
Lung disease 2.00 1.78–2.24 <0.001
Acute/chronic kidney disease 1.33 1.16–1.52 <0.001
Monthly income, NT$
0–15 840 (reference group) 1.00
15 841–25 000 1.02 0.92–1.13 0.726
25 001 0.76 0.65–0.88 <0.001
Geographic region
Northern (reference group) 1.00
Central 1.15 1.02–1.30 0.019
Southern 1.02 0.91–1.14 0.781
Eastern 1.35 1.06–1.73 0.016
Urbanization level
1 (reference group) 1.00
2 1.16 1.02–1.31 0.021
3 1.05 0.91–1.22 0.517
4 1.07 0.92–1.25 0.380
5 1.20 0.99–1.36 0.073
HR, hazard ratio; CI, conﬁdence interval. Hazard ratios were all derived from the
stratiﬁed Cox regression model (stratiﬁed on age and sex) and adjusted for all other
variables.
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PLA pneumonia cases, but only 11.7% of pneumonia cases in the
control group. Thus, the increased risk of pneumonia observed in
this study may very well stem from factors accompanying the
etiologic shift to K. pneumoniae as the primary causative agent of
PLA infections.
This study had two principal strengths. This ﬁrst was our use of
a population-based database which granted us the statistical
power to detect differences between the study and comparison
cohorts. The second was the availability of the etiology of each
diagnosis of PLA and pneumonia. In contrast to most prior studies
which have often lacked the etiology of pneumonia, all PLA and
pneumonia cases in Taiwan are hospitalized and are required to be
tested microbiologically to determine the causative agent.
This study suffered from several limitations. First, the diagnoses
of the conditions analyzed in this study were sourced from an
administrative database using ICD-9-CM codes. These diagnoses
may be less accurate than those collected prospectively according
to standardized procedures. For example, it is possible that some
PLA patients developed right lower lobe atelectasis, which can be
difﬁcult to distinguish clinically from pneumonia. However, all of
the pneumonia patients in this study were evaluated microbio-
logically and had their causative etiology documented. Further-
more, in this study we only utilized discharge diagnoses. This
strongly discounts the possibility that atelectasis would have been
misdiagnosed as pneumonia.
A second limitation is that some clinically relevant patient and
lifestyle information, such as smoking status, alcohol consumption
and dietary habits, body mass index, and the use of pharmaceu-
ticals, all of which may have contributed to these two conditions,
was not available through the administrative dataset. While we did
adjust for urbanization level, which may reﬂect lifestyle, as well as
both obesity and alcohol abuse/dependence syndrome, the
association between PLA and pneumonia may be partially
explained by the residual confounding of unadjusted factors.A ﬁnal limitation is that the PLA patients sourced in this study
had a mean hospital stay of 16.6 days (standard deviation 12.2
days), and hospitalization is clearly a risk factor for the
development of nosocomial pneumonia. However, we performed
a further analysis of our data after excluding PLA subjects whose
pneumonia developed as a complication during hospitalization.
We found that the HR for pneumonia during the 90-day follow-up
period for patients with PLA was 2.71 (95% CI 2.17–3.40) compared
to patients without PLA after adjusting for patient monthly income,
geographic location, urbanization level, hypertension, diabetes,
heart disease, lung disease, and acute/chronic kidney disease.
Therefore, although hospitalization appears to have contributed to
the associations detected in this study, since after excluding
hospitalized pneumonia cases the adjusted HR remained signiﬁ-
cant, it is also very likely that PLA infection is an independent risk
factor for subsequent pneumonia.
In conclusion, this is the ﬁrst study to suggest an increased risk
of pneumonia subsequent to an episode of PLA. Because the vast
majority of post-PLA pneumonia cases are caused by K. pneumo-
niae, and because pneumonia caused by this organism has been
associated with a more complicated course, our ﬁndings can help
clinicians to more appropriately risk-stratify patients who present
with pneumonia after PLA. Future studies will be needed to better
elucidate the mechanisms by which PLA is associated with
subsequent pneumonia.
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